Mireille Vankemmelbeke

University Park
Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.

Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.

Journal: EJNMMI research

Published: September 02, 2025

SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy.

SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy.

Journal: Journal of translational medicine

Published: June 13, 2025

Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.

Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.

Journal: EJNMMI research

Published: March 27, 2025

SC134-TCB Targeting Fucosyl-GM1, a T Cell-Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models.

SC134-TCB Targeting Fucosyl-GM1, a T Cell-Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models.

Journal: Molecular cancer therapeutics

Published: March 15, 2024

Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach.

Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach.

Journal: Molecular diagnosis & therapy

Published: December 05, 2022

An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma.

An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: October 22, 2021

Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.

Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.

Journal: Cancers

Published: November 09, 2020

Molecular and structural basis for Lewis glycan recognition by a cancer-targeting antibody.

Molecular and structural basis for Lewis glycan recognition by a cancer-targeting antibody.

Journal: The Biochemical journal

Published: June 09, 2020

Heterogeneity in the spontaneous induction of the promoter of the ColE9 operon in Escherichia coli.

Heterogeneity in the spontaneous induction of the promoter of the ColE9 operon in Escherichia coli.

Journal: Archives of microbiology

Published: May 31, 2020

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.

Journal: Journal for immunotherapy of cancer

Published: April 26, 2020

Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.

Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.

Journal: Molecular imaging and biology

Published: April 10, 2020

Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement.

Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement.

Journal: Cancer research

Published: November 21, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026